Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingApr 30, 2025Kapsin OintmentCGMP DeviationsApipharma · D-0376-2025Class IIOngoingApr 30, 2025Hemopropin OintmentCGMP DeviationsApipharma · D-0375-2025Class IIOngoingApr 30, 2025Rocuronium Bromide 50 mg per 5mLLack of Assurance of Sterility: Leaking/damaged syringes.Denver Solutions, LLC DBA Leiters Health · D-0374-2025Class IIOngoingApr 30, 2025Ketamine HCl 50mg per 5mLLack of Assurance of Sterility: Leaking/damaged syringes.Denver Solutions, LLC DBA Leiters Health · D-0373-2025Class IIOngoingApr 30, 2025PHENYLephrine HCl in 0.9% Sodium ChlorideLack of Assurance of Sterility: Leaking/damaged syringes.Denver Solutions, LLC DBA Leiters Health · D-0372-2025Class IIOngoingApr 30, 2025dexmedeTOMIDine HCl PFLack of Assurance of Sterility: Leaking/damaged syringes.Denver Solutions, LLC DBA Leiters Health · D-0371-2025Class IIOngoingApr 30, 2025GlycopyrrolateLack of Assurance of Sterility: Leaking/damaged syringes.Denver Solutions, LLC DBA Leiters Health · D-0370-2025Class IIOngoingApr 30, 2025Haloperidol Decanoate InjectionLack of assurance of sterility. Bacterial contamination detected in some media fill unitsAmerisource Health Services LLC · D-0369-2025Class IIOngoingApr 30, 2025Haloperidol Decanoate InjectionLack of assurance of sterility. Bacterial contamination detected in some media fill unitsAmerisource Health Services LLC · D-0368-2025Class IIOngoingApr 30, 2025Haloperidol Decanoate InjectionLack of assurance of sterility. Bacterial contamination detected in some media fill unitsAmerisource Health Services LLC · D-0367-2025Class IIOngoingApr 23, 2025ChlorproMAZINE Hydrochloride TabletsCGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limitThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · D-0366-2025Class IOngoingApr 23, 2025Levetiracetam 0.75% in Sodium Chloride Injection 1LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging...Dr. Reddy's Laboratories, Inc. · D-0365-2025Class IIOngoingApr 23, 2025CIPROFLOXACIN OPHTH SOLUTIONDefective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottleDirect Rx · D-0364-2025Class IIOngoingApr 23, 2025Testosterone Cypionate InjectioncGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.Eugia US LLC · D-0363-2025Class IIOngoingApr 23, 2025Unisom, SleepMinisCGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake LimitChattem Inc · D-0362-2025Class IIOngoingApr 16, 2025chlorproMAZINE Hydrochloride TabletsCGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limitZydus Pharmaceuticals (USA) Inc · D-0361-2025Class IIOngoingApr 16, 2025Proactiv Skin Smoothing ExfoliatorChemical contamination: Presence of benzeneAlchemee, LLC · D-0360-2025Class IIOngoingApr 16, 2025Proactiv Emergency Blemish ReliefChemical contamination: Presence of benzeneAlchemee, LLC · D-0359-2025Class IIOngoingApr 16, 2025Haloperidol Decanoate InjectionLack of Assurance of Sterility: Media fill with bacterial contaminationSomerset Therapeutics Private Limited · D-0358-2025Class IIOngoingApr 16, 2025Haloperidol Decanoate Injection 100mg/mLLack of Assurance of Sterility: Media fill with bacterial contaminationSomerset Therapeutics Private Limited · D-0357-2025Class IIOngoingApr 16, 2025Haloperidol Decanoate Injection 50mg/mLLack of Assurance of Sterility: Media fill with bacterial contaminationSomerset Therapeutics Private Limited · D-0356-2025Class IIOngoingApr 16, 2025Haloperidol Decanoate Injection 50mg/mLLack of Assurance of Sterility: Media fill with bacterial contaminationSomerset Therapeutics Private Limited · D-0355-2025Class IIOngoingApr 16, 2025Methocarbamol Injection USP 1Lack of Assurance of Sterility: Media fill with bacterial contaminationSomerset Therapeutics Private Limited · D-0354-2025Class IIOngoingApr 16, 20250.9% Sodium chloride Irrigation USPPresence of Particulate MatterB. Braun Medical Inc · D-0353-2025Class IIOngoingApr 16, 2025Propafenone Hydrochloride Extended-Release CapsulesCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0352-2025Class IIOngoingApr 16, 2025Propafenone Hydrochloride Extended-Release Capsules USPCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0351-2025Class IIOngoingApr 16, 2025Pravastatin Sodium TabletsCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0350-2025Class IIOngoingApr 16, 2025Pravastatin Sodium TabletsCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0349-2025Class IIOngoingApr 16, 2025Cetirizine Hydrochloride TabletsCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0348-2025Class IIOngoingApr 16, 2025Acetaminophen and IbuprofenCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0347-2025Class IIOngoingApr 16, 2025Naproxen Sodium TabletsCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0346-2025Class IIOngoingApr 16, 2025Saxagliptin TabletsCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0345-2025Class IIOngoingApr 16, 2025Clindamycin Hydrochloride CapsulesCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0344-2025Class IIOngoingApr 16, 2025Lacosamide Tablets 150mgCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0343-2025Class IIOngoingApr 16, 2025Diltiazem Hydrochloride Extended-Release Capsules 12HR 120mgCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0342-2025Class IIOngoingApr 16, 2025Pravastatin Sodium TabletsCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0341-2025Class IIOngoingApr 16, 2025Colesvelam Hydrocholoride Tablets 625mgCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0340-2025Class IIOngoingApr 16, 2025Rosuvastatin Tablets 40mgCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0339-2025Class IIOngoingApr 16, 2025Prochlorperazine Maleate TabletsCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0338-2025Class IIOngoingApr 16, 2025Lacosamide TabletsCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0337-2025